Diagnostics Inc expected to post a loss of 15 cents a share - Earnings Preview

Co-Diagnostics

14/03/2023 20:37

* Co-Diagnostics Inc  CODX.OQ   CODX.O  is expected to show
a fall
in quarterly revenue when it reports  results on March 16. 
    * The Salt Lake City Utah-based  company is expected to
report  a
73.0% decrease in revenue to $5.5 million from $20.4 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Co-Diagnostics Inc
is for
a loss of 15 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $6​, above​ its last closing price of $2.84. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.06       -0.04      -0.04     Met     5.9
 Jun. 30 2022  0.15        0.10       -0.08     Missed  -182.8
 Mar. 31 2022  0.17        0.17       0.34      Beat    96.2​
 Dec. 31 2021  0.12        0.12       0.25      Beat    108.3
 ​​Sep.        0.20        0.21       0.38      Beat    83.9
 30 2021                                                
 Jun. 30 2021  0.22        0.22       0.33      Beat    50​
 Mar. 31 2021  0.22        0.22       0.26      Beat    18.2
 Dec. 31 2020  0.48        0.48       0.45      Missed  -5.6
 This summary was machine generated March 14 at 20:37 GMT.  All
figures in US dollars  unless otherwise stated